Structure of Cytochrome P450: Heme-Binding Site and Heme Reactivity

  • P. R. Ortiz de Montellano
  • S. E. Graham-Lorence
Part of the Handbook of Experimental Pharmacology book series (HEP, volume 105)


Cytochrome P450 enzymes are responsible for the oxidative metabolism of a broad variety of endogenous and exogenous compounds, including sterols, fatty acids, drugs, and xenobiotics. The catalytic diversity required to bind and oxidize the many substrates of this monooxygenase system is possible due to the expression of multiple isozymes, many of which have overlapping substrate specificities. Relatively little is known about the topologies of the cytochrome P450 enzymes or the residues that control substrate specificity even though the complete sequences of over 150 cytochrome P450 isozymes have been determined. The exception to this is cytochrome P450cam, the only member of this family of enzymes for which a crystal structure is available (Poulos et al. 1987). The structure of cytochrome P450cam therefore serves as the template for all current efforts to model the active sites of cytochrome P450 enzymes.


Cytochrome P450 Enzyme Pyrrole Ring Terminal Olefin Active Site Structure Cytochrome P450 Isozyme 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Atkins WM, Sligar SG (1988) The roles of active site hydrogen bonding in cytochrome as revealed by site-directed mutagenesis. J Biol Chem 263: 18842–18849PubMedGoogle Scholar
  2. Atkins WM, Sligar SG (1989) Molecular recognition in cytochrome P-450: alteration of regioselective alkane hydroxylation via protean engineering. J Am Chem Soc 111: 2715–2717CrossRefGoogle Scholar
  3. Connolly ML (1983) Solvent-accessible surfaces of proteins and nucleic acids. Science 221: 709–713PubMedCrossRefGoogle Scholar
  4. De Matteis F, Gibbs AH, Hollands C (1983) N-Alkylation of the haem moiety of cytochrome P-450 caused by substituted dihydropyridines. Biochem J 211: 455–461PubMedGoogle Scholar
  5. Di Primo C, Hui Bon Hoa G, Douzou P, Sligar S (1990) Mutagenesis of a single hydrogen bond in cytochrome P-450 alters cation binding and heme solvation. J Biol Chem 265: 5361–5363PubMedGoogle Scholar
  6. Edwards RJ, Murray BP, Boobis Ar, Davies DS (1989) Identification and location of α-helices in mammalian P450. Biochemistry 28: 3762–3770PubMedCrossRefGoogle Scholar
  7. Gotoh O, Fujii-Kuriyama Y (1989) Evolution, structure, and gene regulation of cytochrome P-450. In: Ruckpaul K (ed) Frontiers in biotransformation. Taylor and Francis, London, pp 195–243Google Scholar
  8. Graham-Lorence S, Khalil MW, Lorence MC, Mendelson CR, Simpson ER (1991) Structure-function relationship of human aromatase cytochrome P-450 using molecular modeling and site-directed mutagenesis. J Biol Chem 266: 11939–11946PubMedGoogle Scholar
  9. Imai M, Shimada H, Watanabe Y, Matsushima-Hibiya Y, Makino R, Koga H, Horiuchi T, Ishimura Y (1989) Uncoupling of the cytochrome P-450cam monooxygenase reaction by a single mutation, threonine-252 to alanine and valine: a possible role of the hydroxy amino acid in oxygen activation. Proc Natl Acad Sci USA 86: 7823–7827PubMedCrossRefGoogle Scholar
  10. Jerina DM, Sayer JM, Yagi H, van Bladeren PJ, Thakker DR, Levin W, Chang RL, Wood AW, Conney AH (1985) Stereoselective metabolism of polycyclic aromatic hydrocarbons to carcinogenic metabolites. In: Boobis AR, Caldwell J, DeMatteis F, Elcombe CR (eds) Microsomes and drug oxidations. Taylor and Francis, London, pp 310–319Google Scholar
  11. Jonen HG, Werringloer J, Prough RA, Estabrook RW (1982) The reaction of phenylhydrazine with microsomal cytochrome P-450. Catalysis of heme modification. J Biol Chem 257: 4404–4411PubMedGoogle Scholar
  12. Juvonen RO, Iwasaki M, Negishi M (1991) Structural function of residue 209 in coumarin 7-hydroxylase (P450coh): enzyme-kinetic studies and site-directed mutagenesis. J Biol Chem 266: 16431–16435PubMedGoogle Scholar
  13. Kadlubar FF, Hammons GJ (1987) The role of cytochrome P-450 in the metabolism of chemical carcinogens. In: Guengerich FP (ed) Mammalian cytochromes P- 450. CRC Press, Boca Raton, pp 81–130Google Scholar
  14. Kronbach T, Kemper B, Johnson EF (1991) A hypervariable region of P450IIC5 confers progesterone 21-hydroxylase activity to P450IIC1. Biochemistry 30: 6097–6102PubMedCrossRefGoogle Scholar
  15. Kunze KL, Mangold BLK, Wheeler C, Beilan HS, Ortiz de Montellano PR (1983) The cytochrome P-450 active site: regiospecificity of prosthetic heme alkylation by olefins and acetylenes. J Biol Chem 258: 4202–4207PubMedGoogle Scholar
  16. Laughton CA, Neidle S, Zvelebil MJ, Sternberg MJ (1990) A molecular model for the enzyme cytochrome P450(17 alpha), a major target for the chemotherapy of prostatic cancer. Biochem Biophys Res Commun 171: 1160–1167PubMedCrossRefGoogle Scholar
  17. Lee JS, Jacobsen NE, Ortiz de Montellano PR (1988) 4-Alkyl radical extrusion in the cytochrome P450-catalyzed oxidation of 4-alkyl-l,4-dihydropyridines. Biochemistry 27: 7703–7710Google Scholar
  18. Lindberg RLP, Negishi M (1989) Alteration of mouse cytochrome P450coh substrate specificity by mutation of a single amino-acid residue. Nature 339: 632–634PubMedCrossRefGoogle Scholar
  19. Martinis SA, Atkins WM, Stayton PS, Sligar SG (1989) A conserved residue of cytochrome P-450 is involved in heme-oxygen stability and activation. J Am Chem Soc 111: 9252–9253CrossRefGoogle Scholar
  20. McCluskey SA, Whitney RA, Marks GS (1989) Evidence for the stereoselective inhibition of chick embryo hepatic ferrochelatase by N-alkylated porphyrins. Mol Pharmacol 36: 608–614PubMedGoogle Scholar
  21. Meyer UA, Gut J, Kronbach T, Skoda C, Meier UT, Catin T (1986) The molecular mechanisms of two common polymorphisms of drug oxidation - evidence for functional changes in cytochrome P-450 isozymes catalyzing bufuralol and mephenytoin oxidation. Xenobiotica 16: 449–464PubMedCrossRefGoogle Scholar
  22. Narhi LO, Fulco AJ (1986) Characterization of a catalytically self-sufficient 119000- dalton cytochrome P-450 monooxygenase induced by barbiturates in Bacillus megaterium. J Biol Chem 261: 7160–7169PubMedGoogle Scholar
  23. Nelson DR, Strobel HW (1988) On the membrane topology of vertebrate cytochrome P-450 proteins. J Biol Chem 263: 6038–6050PubMedGoogle Scholar
  24. Nelson DR, Strobel HW (1989) Secondary structure prediction of 52 membrane-bound cytochromes P450 shows a strong structural similarity to P450cam. Biochemistry 18: 656–660CrossRefGoogle Scholar
  25. Ortiz de Montellano PR (1985) Alkenes and alkynes. In: Anders MW (ed) Bioactivation of foreign compounds. Academic, New York, pp 121–155Google Scholar
  26. Ortiz de Montellano PR (1986) Oxygen activation and transfer. In: Ortiz de Montellano PR (ed) Cytochrome P-450: structure, mechanism, and biochemistry. Plenum, New York, pp 217–273Google Scholar
  27. Ortiz de Montellano PR, Beilan HS, Kunze KL (1981a) N-Methylprotoporphyrin IX: chemical synthesis and identification as the green pigment produced by 3,5-diethoxycarbonyl-l,4-dihydrocollidine treatment. Proc Natl Acad Sei USA 78: 1490–1494Google Scholar
  28. Ortiz de Montellano PR, Beilan HS, Kunze KL (1981b) N-Alkylprotoporphyrin IX formation in 3,5-dicarbethoxy-l,4-dihydrocollidine-treated rats. Transfer of the alkyl group from the substrate to the porphyrin. J Biol Chem 256: 6708–6713Google Scholar
  29. Ortiz de Montellano PR, Mico BA, Mathews JM, Kunze KL, Miwa GT, Lu AYH (1981c) Selective inactivation of cytochrome P-450 isozymes by suicide substrates. Arch Biochem Biophys 210: 717–728Google Scholar
  30. Ortiz de Montellano PR, Kunze KL, Beilan HS (1983a) Chiral orientation of prosthetic heme in the cytochrome P-450 active site. J Biol Chem 258: 45–47Google Scholar
  31. Ortiz de Montellano PR, Mangold BLK, Wheeler C, Kunze KL, Reich NO (1983b) Stereochemistry of cytochrome P-450-catalyzed epoxidation and prosthetic heme alkylation. J Biol Chem 258: 4208–4213Google Scholar
  32. Ortiz de Montellano PR, Stearns RA, Langry KC (1984) The allylisopropylacetamide and novonal prosthetic heme adducts. Mol Pharmacol 25: 310–317Google Scholar
  33. Ozols J (1986) Complete amino acid sequence of a cytochrome P-450 isolated from ß-napthoflavone-induced rabbit liver microsomes. J Biol Chem 261: 3965–3979PubMedGoogle Scholar
  34. Poulos TL, Finzel BC, Howard AJ (1987) High-resolution crystal structure of cytochrome P450cam. J Mol Biol 195: 687–700PubMedCrossRefGoogle Scholar
  35. Raag R, Swanson BA, Poulos TL, Ortiz de Montellano PR (1990) Formation, crystal structure, and rearrangement of a cytochrome P450cam iron-phenyl complex. Biochemistry 29: 8119–8126PubMedCrossRefGoogle Scholar
  36. Shimizu T, Sadeque AJM, Sadeque GN, Hatano M, Fujii-Kuriyama Y (1991a) Ligand binding studies of engineered cytochrome P-450d wild type, proximal mutants, and distal mutants. Biochemistry 30: 1490–1496PubMedCrossRefGoogle Scholar
  37. Shimizu T, Ito O, Hatano M, Fujii-Kuriyama Y (1991b) CO binding studies of engineered cytochrome P-450ds: effects of mutations at putative distal sites in the presence of polycyclic hydrocarbons. Biochemistry 30: 4659–4662PubMedCrossRefGoogle Scholar
  38. Swanson BA, Ortiz de Montellano PR (1991) Structure and absolute stereochemistry of the four N-phenylprotoporphyrin IX regioisomers isolated from phenyl-hydrazine-treated myoglobin. J Am Chem Soc 113: 8146–8153CrossRefGoogle Scholar
  39. Swanson BA, Dutton DR, Lunetta JM, Yang CS, Ortiz de Montellano PR (1991) The active sites of cytochromes P450 IA1, IIB1, IIB2, and IIE1. Topological analysis by in situ rearrangement of phenyl-iron complexes. J Biol Chem 266: 19258–19264PubMedGoogle Scholar
  40. Swanson BA, Halpert JR, Bornheim LM, Ortiz de Montellano PR (1992) Topological analysis of the active sites of cytochrome P450IIB4 (rabbit), P450IIB10 (mouse) and P450IIB11 (dog) by in situ rearrangement of phenyl- iron complexes. Arch Biochem Biophys 292: 42–46PubMedCrossRefGoogle Scholar
  41. Tuck SF, Peterson JA, Ortiz de Montellano PR (1992) Active site topologies of bacterial cytochromes P450101 (P450cam), P450108 (P450terp), and P450102 (P450Bm-3): in situ rearrangement of their phenyl-iron complexes. J Biol Chem 267: 5614–5620PubMedGoogle Scholar
  42. Waxman DJ, Walsh C (1982) Phenobarbital-induced rat liver cytochrome P-450. Purification and characterization of two closely related isozymic forms. J Biol Chem 257: 10446–10457PubMedGoogle Scholar
  43. Wolff T, Distlerath LM, Worthington MT, Groopman JD, Hammons GJ, Kadlubar FF, Prough RA, Martin MV, Guengerich FP (1985) Substrate specificity of human liver cytochrome P-450 debrisoquine 4-hydroxylase probed using immunochemical inhibition and chemical modeling. Cancer Res 45: 2116–2122PubMedGoogle Scholar
  44. Wu D-A, Hu M-C, Chung B-C (1991) Expression and functional characterization of P450c21 in S. cerevisiae in relation to its deficiency. International symposium on cytochromes P-450 of microorganisms, Berlin July 24–27Google Scholar
  45. Zhou D, Pompon D, Chen S (1991) Structure-function studies of human aromatase by site-directed mutagenesis: kinetic properties of mutants Pro-308 → Phe, Tyr-361 → Phe, Tyr-361 → Leu, and Phe-406 → Arg. Proc Natl Acad Sci USA 88: 410–414PubMedCrossRefGoogle Scholar
  46. Zvelebil MJJM, Wolf CR, Sternberg MJE (1991) A predicted three-dimensional structure of human cytochrome P450: implications for substrate specificity. Protein Eng 4: 271–282PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1993

Authors and Affiliations

  • P. R. Ortiz de Montellano
  • S. E. Graham-Lorence

There are no affiliations available

Personalised recommendations